ArticleBMC pediatrics2026
Acute kidney injury: incidence, risk factors, and early outcomes in hospitalized children with sickle cell disease attending a tertiary hospital in Eastern Uganda.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany sickle cell disease (SCD) patients experience renal damage that impairs function, with acute kidney injury (AKI) significantly affecting both immediate and long-term outcomes. The only Ugandan study on this subject reported a high incidence and mortality of AKI among children with SCD, but did not assess other outcomes.
methodsThis hospital-based prospective study was conducted between January and June 2024 at Jinja Regional Referral. AKI was diagnosed using KDIGO criteria, and participants were followed until discharge or death. Outcomes included length of hospital stay, mortality, and referral. Data were analyzed using SPSS v26, with Modified Poisson regression to identify significant risk factors (P < 0.05).
resultsA total of 117 children were enrolled, slightly more females (52.1%) than males. Most were under 10 years, with 40.2% below 5 years and 42.7% aged 5–9 years? AKI occurred in 30 children, an incidence proportion of 25.6%. Independent risk factors for AKI included older age (aRR = 1.416), not using hydroxyurea (aRR = 1.628), frequent Nonsteroidal Anti Inflammatory Drugs (aRR = 1.186) use for pain, presence of other illnesses (aRR = 1.995), more than one transfusion in the preceding 6 months (aRR = 1.540), and stunting (aRR = 1.204) (P < 0.05 for all). Overall mortality was 5.1% (6/117), all occurring in children with AKI, giving a mortality of 20% in this group (P < 0.001). Prolonged hospital stay was significantly more common in the AKI group (54.5% vs. 13.8%, P < 0.001).
conclusionsThe incidence of AKI was high, affecting one quarter of participants. Routine AKI screening is recommended for all SCD admissions. Ensuring hydroxyurea availability, educating patients on safe analgesic use, and close monitoring of SCD children with AKI could reduce mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.